Wuhan Hygeianey Biological Technology co., LTD

About us
Current location:
Home page
>
>
>
Britain successfully mapped the oncogenic protein "social networking" Atlas booster anti-cancer drug development
News

Britain successfully mapped the oncogenic protein "social networking" Atlas booster anti-cancer drug development

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2016-12-28 14:33
  • Views:0

(Summary description)Cancer Research UK recently issued a press release said that the researchers designed a new calculation model, by analyzing theoncogenic protein differs from non-oncogenic proteins unique behavior, draw these proteins "social network" map for the development of anti-cancer new drugs provide a new boost. Related research published in the latest issue of "Public Library ofScience Computational Biology Volume.

Britain successfully mapped the oncogenic protein "social networking" Atlas booster anti-cancer drug development

(Summary description)Cancer Research UK recently issued a press release said that the researchers designed a new calculation model, by analyzing theoncogenic protein differs from non-oncogenic proteins unique behavior, draw these proteins "social network" map for the development of anti-cancer new drugs provide a new boost. Related research published in the latest issue of "Public Library ofScience Computational Biology Volume.

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2016-12-28 14:33
  • Views:0
Information

Cancer Research UK recently issued a press release said that the researchers designed a new calculation model, by analyzing theoncogenic protein differs from non-oncogenic proteins unique behavior, draw these proteins "social network" map for the development of anti-cancer new drugs provide a new boost. Related research published in the latest issue of "Public Library ofScience Computational Biology Volume."

The researchers found that there are many interactive molecular pathways affects the development of cancer, those anti-cancer drugs"targeting" of the oncogenic protein, compared with non-oncogenic protein tend to have a special "social behavior" characteristics. In their view, this indicates that a number of previously undetected or targeting oncogenic proteins should also have similar characteristics, but also can be an effective drug targets. For many other proteins can "communicate" and "hub" proteins, the researchers likened it has thousands of Facebook friends super users who are more likely to cause cancer.

  

Britain

 

  第十九届全国肿瘤学大会暨2016年CSCO学术会议、第九届中国生物产业大会、2016年中华医学会全国检验医学学术大会、第九届中国肿瘤学术大会、中国防痨协会2016年全国学术大会、2016年中华医学会病理年会、2016年中国国际医疗器械博览会等会议上,海吉力生物的身影随处可见。每一个新产品的面试都获得了市场的满满好评,“ACTC循环肿瘤细胞检测试剂盒”成为了今年学术会、展销会上的明星产品。肿瘤靶向药物用药诊断、药物代谢能力检测、传染病筛查等系列产品,已经覆盖全国范围内200余家医院及第三方实验室。

 

【年终记】精准医疗浪潮中奋勇前行的海吉力生物

 

  2016年全年,国内数十家医疗单位实验室采用海吉力生物自主研发生产的“人类EGFR基因突变检测试剂盒”、“人类KRAS基因7种突变检测试剂盒”参加各类室间质评活动,满分通过“2016年卫生部临检中心室间质量评价”、“2016年CNAS/PQCC分子检测能力验证”、“2016年全国肿瘤游离DNA基因突变检测室间质评调查活动”、全国多个省市的“临床病理室间质控”,充分体现了海吉力生物产品优异稳定的质量、卓越的临床应用性能,同时也获得了各实验室对海吉力生物产品性能的认可。优异的产品、完善的服务、客户的认同,就是海吉力生物不懈的追求。

  

【年终记】精准医疗浪潮中奋勇前行的海吉力生物

 

  2017年度,海吉力生物将继续携手各界临床医学检验和科研的专家朋友们,共同致力于肿瘤个体化基因检测、药物代谢能力检测、传染病筛查、临床检验等领域的发展。在精准医疗的道路上,有你有我,海吉力生物愿与您执手前行!

Scan the QR code to read on your phone

Copyright©Wuhan Hygeianey Biological Technology Co., LTD